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ABSTRACT 
Objective: Bile duct ligation (BDL), chronic liver injury model, was extensively used in studying mechanisms of fibrogenesis and antifibrotic agents. 
Considering the liver regenerative capacity and the diverse results from BDL, the present study aimed to evaluate the biochemical and 
histopathological changes over 10 weeks following BDL assessing if BDL-induced changes remain in a deterioration state or improve at a certain 
stage.  
Methods: Sham operation and BDL were conducted in Male Wistar rats. Serum AST, ALT, total bilirubin and albumin and hepatic hydroxyproline 
(HYP), reduced glutathione (GSH) and malondialdehyde (MDA) were measured in sham-operated (n=3) and BDL-rats (n=6) at 0, 1, 2, 4, 6, 8 and 10 
weeks following operation. Liver tissue was also processed for histopathological analysis (H&E and Sirus red staining).  
Results: Progressive liver injury (H&E) and collagen deposition (Sirus red and HYP) in BDL-rats were observed starting from the first week post-
operation and reached their maximum with early signs of cirrhosis on the 10th week of BDL. Severe and sustained cholestatic injury appeared in 2 
weeks (increased ALT, AST, bilirubin along with decreased albumin (P<0.001) compared to sham-operated rats). AST peaked on first week, 
however, bilirubin, ALT and MDA peaked on the 4th week (P<0.001) then gradually decreased compared to their peaks.  
Conclusion: The relative improvement in liver function/cholestasis following their peaks in BDL model despite progression of fibrosis and hepatic 
injury require investigators using this model to consider not only biochemical, but also histopathological findings to guarantee an accurate 
interpretation of their results.  
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INTRODUCTION 
Chronic liver diseases are common and potentially life threatening 
for humans. These involve progressive injury and regeneration of 
liver parenchyma leading to fibrosis and subsequently liver cirrhosis 
[1]. Massive deposition of extracelluler matrix components in the 
liver as wound-healing response to repeated liver injury results in 
liver fibrosis [2, 3]. At some stages of the disease, the liver 
regenerates to respond to a loss of liver mass or liver injury 
retrieving some of its lost functions[3]. Minimum 50% hepatocyte 
loss and presence of hepatocytes replicative senescence are 
necessary triggers for liver progenitor cells (LPC) activation. 
Inhibition of the LPC proliferation and impairment of liver 
regeneration was achieved after 70% partial hepatectomy [4]. 
Studying fibrogenesis and possible antifibrotic drugs would 
therefore require a model that most closely mirror advanced human 
fibrotic liver diseases. 
Different rodent models, developed to mimic human hepatic fibrosis, 
are valuable to understand disease etiology and pathology, as well as 
to test therapeutic approaches that cannot be safely applied to 
humans [5, 6]. Bile duct ligation (BDL) model has attracted many 
investigators studying (i) the underlying cellular and molecular 
mechanisms of fibrogenesis [7, 8] and (ii) the assessment of the 
efficacy of various antifibrotic agents[9]. It is considered as a 
representative chronic liver injury model that is mediated by biliary 
obstruction and subsequent cholestasis [10]. Double ligation of the 
common bile duct with dissection between the ligatures causes 
abnormal flux of bile acids and bilirubin in the liver. Toxic 
hydrophobic bile salts subsequently accumulate within hepatocytes 
causing successive inflammatory reactions, hepatocyte death and 
peri ductular fibrosis [11, 12]. Models of BDL employed at different 
time points up to 6 weeks following BDL revealed diverse results 
[13-15]. A 3 or 4-week BDL-rat model is the most commonly used by 
many investigators testing possible antifibrogenic drugs in 
prophylactic or curative study designs [16-18]. Nonetheless, some 
treatment regimens may require prolonged duration and so two 
important questions come up: (i) Do the changes induced by BDL 
remain in a deterioration state or improve at a certain stage because 
of self regeneration? (ii) Is the study designed in a way that 
guarantees the correct/accurate interpretation of results? The 
current study was designed therefore to evaluate the BDL model 
over 10 weeks following BDL and verify the suitable duration of BDL 
at which the efficiency of possible anti-fibrotic drugs can be tested to 
exclude model specific artifacts and to strengthen the data obtained. 
MATERIALS AND METHODS 
Male Wistar rats weighting 250±30 g (n=57) were obtained from animal 
facility of the National Institute for Vaccination, Helwan, Egypt. The 
temperatureainkeptwereanimals - humidityand -controlled 
environment in a 12-h light-dark cycle. Rats were acclimatized for 1 
week before any experimental procedures and were allowed free access 
to water and standard rodent chow at all times. All animal experiments 
received approval from the Ethical Committee of the Faculty of 
Pharmacy, Zagazig University, Egypt (No. P11/2/2013). 
Experimental model 
Rats were generally anesthetized with an intraperitoneal injection of 
ketamine hydrochloride (50 mg/kg) and diazepam (3 mg/kg). Under 
aseptic conditions, double ligation at the common bile duct and 
complete cutting at midpoint were conducted in 36 rats (BDL). The 
other 21 rats were sham-operated; received an identical laparotomy 
and isolation of the common bile duct without ligation [19]. 
Blood samples were obtained via retro-orbital bleeding from either 
sham-operated (n=3 rats) and BDL rats (n = 6 rats) at time of 
operation as well as 1, 2, 4, 6, 8 and 10 weeks thereafter. Serum 
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samples were frozen at-20 °C for subsequent measurement of 
aspartate aminotransferase (AST) and alanine aminotransferase 
(ALT) activities, total bilirubin and albumin. All rats were euthanized 
following blood withdrawal and liver tissues were harvested and 
washed in normal saline. Each liver was divided into three parts. 
Two parts were quickly frozen in liquid nitrogen (-170 °C) and 
stored at-20 °C for subsequent determination of hepatic 
hydroxyproline (HYP), reduced glutathione (GSH), malondialdehyde 
(MDA) content. The third part of liver tissue samples was 
immediately fixed in 10% formalin at 4 °C and embedded in paraffin 
for subsequent histopathological analysis.  
Liver function tests 
Serum concentrations of liver enzymes (ALT and AST), albumin and 
total bilirubin were assayed using commercially available kits 
provided by Spinreact, Gerona, Spain following manufacturer’s 
instructions. 
Hepatic hydroxyproline content  
Hydroxyproline content determination was performed 
spectrophotometrically using Ehrlich reagent [20]. Briefly, liver 
tissue was homogenized in 6 N HCl and was incubated at 120⁰C for 
12 hrs (hydrolysis). The filtered acid hydrolysate (5 µl) was applied 
to 96-wells plate and 5 µl of citric/acetate buffer and 100 µl 
chloramine T solution were added. The plate was incubated for 20 
minutes at room temperature before the addition of 100 µl Ehrlich 
solution. The plate was then incubated for 15 minutes at 65⁰C and 
The O. D was read at 550 nm using microplate reader (Sunrise plate 
reader, Austria). The concentration of hydroxyproline in the 
hydrolyzed samples was determined from hydroxyproline standard 
curve which was established using serial dilutions of 1 mg/ml 
hydroxyproline (sigma, St. Louis, Mo). 
Hepatic lipid peroxide and reduced glutathione (GSH) content  
Liver tissue was homogenized in ice-cold phosphate buffered saline, 
pH 7.2 to prepare 10 % homogenate. The resultant homogenate was 
used for spectrophotometric determination of MDA and GSH using 
Biodiagnostics kits (Biodiagnostics Co., Giza, Egypt) following 
manufacturer’s instructions. 
Histopathological examination 
The paraffin-embedded liver tissue was sectioned (4 mm thickness) 
and stained with H&E using standard histological techniques. All 
slides were blindly examined. Sirius Red staining was performed by 
incubating slides in 0.1% Sirius Red F3B for 1 h, washing twice in 
acidified water, dehydrating thrice in 100% ethanol, and then 
clearing in xylene. The percent of fibrosis were measured using 
image J software and expressed as a percentage of total analyzed 
areas. Histopathological scoring of the liver was done according to 
the Metavir score. The Metavir score is a semiquantitative 
classifications system consisting of an activity and a fibrosis score: 
The fibrosis score is assessed on a five point scale (0 = no fibrosis, 1 
= portal fibrosis without septa, 2 = few septa, 3 = numerous septa 
without cirrhosis, 4 = cirrhosis). The activity score was graded 
according to the intensity of necroinflammatory lesions (A0 = no 
activity, A1 = mild activity, A2 = moderate activity, A3 = severe 
activity)[21]. 
Statistical analysis 
All statistical analyses were done using Windows-based Statistical 
Package for Social Sciences software (SPSS version 14.0, SPSS Inc, 
Chicago, IL). Results were expressed as mean±SD. Statistical 
difference were sought using Student’s t-test or one-way analysis of 
variance (ANOVA) followed by LSD post-hoc test (if more than two 
sets of data were being compared), taking p<0.05 as statistically 
significant. 
RESULTS 
Histopathological findings  
The progression of liver injury over 10 weeks following BDL was 
initially evaluated by histological examination (fig. 1). The sham 
group (fig. 1A) showed normal hepatocytes arranged in branching 
cords radiating from the central vein (CV). The nuclei are central and 
rounded and the cytoplasm was granular and acidophilic. Normal 
sinusoidal space and periportal area were also observed. No 
inflammatory activity could be seen. BDL exhibited progressive 
increase in the level of bile duct proliferation (arrows) and cellular 
inflammatory response (arrow heads) after 1 week (fig. 1B), 2 weeks 
(fig. 1C), 4 weeks (fig. 1D), 6 weeks (fig. 1E), 8 weeks (fig. 1F) and 
reached its maximum levels at 10 weeks after BDL (fig. 1G). Early 
signs of cirrhosis were detected in liver sections of rats on week 10 
post BDL. Congested blood vessels were also noticed in all operated 
groups (asterisk).  
Marked degree of hepatocytes injury was noticed. Hepatocytes 
were vacuolated in (fig. 1D) and some of them had pkynotic 
shrunken nuclei after 6 to 10 weeks of BDL (fig. 1E to fig. 1G). 
Karyolysis was observed in 8 to 10 weeks after BDL. Connective 
tissue (CT) started to appear at the 6 weeks and increased 
progressively by 10 weeks of BDL.  
 
 
Fig. 1: Liver tissue sections from sham operated rats (A) and 
rats with BDL, on post-operative week 1 (B), week 2 (C), week 2 
(D), week 6 (E), week 8 (F) and week 10 (G), stained with 
hematoxylene and eosin. Bile duct proliferation (arrows) and 
cellular inflammatory response (arrow heads) and Congested 
blood vessels (asterisk). Results are representative of three 
animals at each time point; original magnification X 100 
 
Fibrogenic response in BDL-induced liver injury 
Sirus red staining of liver tissue sections was utilized to assess for the 
extent of fibrosis. Sham animals showed the lowest level of collagen 
deposition, as anticipated (fig. 2A). A significant progressive increase 
in collagen deposition in BDL-rats was observed after 1 week (fig. 2B), 
2 weeks (fig. 2C), 4 weeks (fig. 2D), 6 weeks (fig. 2E), 8 weeks (fig. 2F) 
and reached its maximum levels at 10 weeks after BDL (fig. 2G).  
The quantitation of fibrosis area (fig. 2H) revealed a time-dependent 
progression of fibrosis in BDL rats compared to sham-operated rats 
(P<0.001). Metavir scoring at different time points following BDL is 
illustrated in fig. 2I. In confirmation, a time-dependent progressive 
increase in hepatic HYP content was perceived in BDL-rats throughout 
10 weeks duration following operation (P<0.01 at fist week following 
BDL and P<0.001 thereafter) as compared to corresponding sham-
operated rats (fig. 3).  
Serum biochemical tests indicating cholestatic liver injury 
Serum biochemical tests monitored over 10 weeks (fig. 4) 
demonstrated that BDL-operated rats developed severe and 
sustained cholestatic injury characterized by significant increases 
liver enzymes (ALT and AST), bilirubin along with decrease in serum 
albumin compared to sham-operated rats (P<0.001). The peak of 
serum ALT and AST were observed at week 4 (412%) and at week 1 
(615%) from corresponding sham groups, respectively. Such peaks 
in ALT and AST were followed by significant gradual decreases in 
enzyme activities compared to their peak values (P<0.001). 
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Fig. 2: Liver tissue sections from sham operated rats (A) and 
rats with BDL, on post-operative week 1 (B), week 2 (C), week 2 
(D), week 6 (E), week 8 (F) and week 10 (G), stained with sirus 
red. Representative photographs of liver sections from three 
different animals at each time point, and three randomly 
selected areas from each section were analyzed. (H) Sirus red 
stained liver tissue sections from rats with sham operation, or 
with BDL at different time points after surgery (weeks 1, 2, 4, 6, 
8 and 10) were measured using image J software and expressed 
as a percentage of total analyzed area (% fibrosis). Results are 
means±SD from 9 consecutive fields; ***P˂0.001 as compared 
to sham groups. Original magnification X 100. (I) Metavir 
scoring at different time point following BDL 
 
Fig. 3: Hydroxy proline (HYP) content in liver tissues of BDL-
and sham-operated rats at different time durations after BDL. 
Results were expressed as mean±SD, n=3 and 6 for sham and 
BDL groups respectively. *P˂0.05, **P˂0.01, ***P˂0.001 as 
compared to sham groups 
 
At all time points ALT and AST activities in BDL-rats were higher 
than those in sham-operated rats (P<0.001). Serum total bilirubin 
attained its maximum level (7.7±0.46 mg/dl) after 4 weeks of 
operation. This peak was followed by significant gradual reduction 
thereafter. Conversely, the decrement in serum albumin was readily 
detected after 2 weeks of BDL (P˂0.001). 
Hepatic MDA and GSH contents  
The level of MDA, a marker of lipid peroxidation, increased by 300% and 
276% in the 2nd and 4th weeks after BDL respectively as compared to the 
sham groups (P<0.001). Afterward, there was a gradual decrease in 
hepatic MDA (P<0.001 compared to MDA peak at 4th week). Unlike other 
parameters, hepatic MDA content in BDL-rats was similar to that of 
sham-operated rats at weeks 8 and 10 postoperative (fig. 5A). 
Conversely, BDL-induced cholestasis resulted in a notable time-
dependent depletion of total GSH content all the way through the 10 
weeks duration compared to the sham group (fig. 5B). 
 
 
Fig. 4: Serum biochemical tests of cholestatic liver injury induced by BDL. Serum concentration of (A) ALT, (B) AST, (C) total bilirubin and 
(D) albumin were measured in BDL-rats and sham-operated rats at different time points up to 10 weeks following surgery. Results were 
expressed as mean±SD and n=3 and 6 for sham and BDL groups respectively. ***P˂0.001 as compared to sham groups and ###P˂0.001 as 
compared to peak value 
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Fig. 5: Hepatic MDA (A) and GSH (B) content in BDL-and sham-
operated rats at different time durations after BDL. Results 
were expressed as mean±SD, n=3 and 6 for sham and BDL 
groups, respectively. *P˂0.05, **P˂0.01, ***P˂0.001 as compared 
to sham groups and ###P˂0.001 as compared to peak value 
 
DISCUSSION 
Bile duct ligation (BDL) is the most common model used to induce 
obstructive cholestatic injury in mice and rats. Biliary obstruction 
can lead to hepatocellular injury, which is followed by bile duct 
proliferation, fibrosis and cirrhosis. Depending on the obstruction 
time, an acute or chronic hepatic damage can take place [22]. 
Different studies of BDL model revealed diverse results regarding 
their outcomes of either fibrosis and/or cirrhosis [13-15,23]. In the 
current study BDL provided an acute obstructive jaundice in two 
weeks, and progressed to fibrosis in 4 to 10 weeks. Cirrhosis started 
to show early signs by the end of experiment at week 10 post 
operation. Previous study BDL model in rats over 6 weeks similarly 
reported acute obstructive jaundice in two weeks, but progressed to 
cirrhosis in 4 or 6 weeks [24]. All murine models of cholestatic liver 
fibrosis show several characteristics leading to liver injury including 
direct damage of the biliary epithelial cells induced by obstruction, 
immune responses leading to infiltration of mononuclear cells and 
periductular inflammation [6]. In consistence with these, the present 
study showed that BDL operation caused progressive increase in 
bile duct proliferation and cellular inflammatory response started as 
early as 1 week postoperation and lasts till week 10 postoperative. 
Percent of hepatic fibrosis area increased with formation of a fibrous 
connective tissue bridge between the portal tracts in BDL-rats. 
These findings were in agreement with other studies [16,25-27]. 
Liver fibrosis increased in a time-dependent fashion throughout 10 
weeks following BDL. It is well known that liver fibrosis is 
characterized by excessive accumulation of extracellular matrix 
(ECM) proteins such as type I and type IV collagen within the 
perisinusoidal space of Disse [28]. The accumulation of collagen, was 
assessed by a significant increase in hepatic hydroxyproline content 
in BDL-rats which gradually increased from the 1st week of BDL 
operation till reach its maximum at the end of our experiment in the 
10th week of BDL operation.  
Although histological changes were progressive following complete 
blockage of bile acid flow; up to week 10 postoperative, biochemical 
changes were not in complete harmony. Serum total bilirubin level 
dramatically elevated till reached its peak after 4 weeks of BDL 
operation. It also induced severe inflammation in both blood and 
hepatic tissue, determined by drastic increases of hepatocyte 
aminotransferases (ALT peaked on week 4, while AST peaked on 
week 1 of BDL). The decrements of serum total bilirubin and hepatic 
aminotransferases following their peaks are in consistence with 
previous studies [29,30].  There is accumulating evidence that 
several hepatic transporters undergo adaptive regulation in 
response to cholestatic liver injury. This adaption are presumed to 
minimize the hepatic retention of bile acids and other potentially 
toxic substrates and this may explain the decline in total bilirubin 
seum level started on week 6 of BDL [31]. It is quite possible that 
this response only reflects a non-effective consequence to the 
accumulation of toxic bile constitutes in hepatocytes [32].  
Moreover, Hepatocytes are able to develop number of secondary 
adaptive changes to minimize the detrimental effects of toxic biliary 
compounds retained as a consequence of the secretory failure. This 
may explain the decline of serum ALT and AST following their peaks 
[33]. A BDL models over a period of 6 weeks showed ALT peak on 
week 2 following BDL and decline started on week 3 throughout the 
6 weeks postoperative [15]. As early as 5 days postoperative, ALT 
and bilirubin were reported to max out and declines were observed 
10 weeks after BDL[29]. Likewise, ALT and AST were reported to 
attain their peaks at day 2 and day 1 respectively after BDL [34]. 
Another 4 weeks model wasn’t able to show any peaks in AST [35] 
that was observed on 1st week in our model.  
The decline in serum albumin level subsequent to BDL is in 
agreement with reported studies [36],[37]. Henriksen and colleuges 
[38] reported that patients with advanced cirrhosis almost always 
have hypoalbuminemia caused both by decreased synthesis by the 
hepatocytes and water and sodium retention that dilutes the content 
of albumin in the extracellular space. Other factors likely contribute 
to the development of hypoalbuminemia, including an increased 
transcapillary transport rate [39].  
Hepatic oxidative stress was previously reported in different BDL 
models [17,40-44] Previous studies reported a status of oxidative 
stress, depletion of reduced GSH[17,40,41] and increase in lipid 
peroxides induced by accumulated bile acids in BDL models[42-44] 
as seen in our model. The time-dependent depletion of hepatic 
reduced GSH may occur through the detergent action and 
cytotoxicity of the retained bile salts which is partly responsible for 
the plasma membrane damage seen in BDL models leading to 
further oxidative stress resulting in extensive release of reactive 
oxygen species that most likely attributed to a lack of adequate 
reactive oxygen species scavengers leading to this depletion in 
hepatic reduced GSH content [45]. 
Concurrently, hepatic MDA peaked after 4 weeks of BDL then 
unexpectedly declined starting from week 6 thereafter till reached 
normal on weeks 8 and 10. This result is in harmony with previous 
reported study[46]. Such decline in MDA could be due to its 
consumption in cross linking of collagen as MDA has been illustrated 
to possess fibroblast-stimulating properties in culture. Collagen 
production was amplified by 2–3 times in cultured fibroblasts 
treated with MDA [47]. 
CONCLUSION 
Cholestasis liver injury induced by BDL induced progressive changes 
in the hepatic architecture, namely inflammation and fibrosis. The 
liver function tests and hepatic MDA peeked at different time points 
following BDL and then gradually declined. Previous studies on rat 
model of BDL and our study revealed the possibility of marked strain 
differences in fibrosis susceptibility and therefore the importance of 
conducting preliminary groups of BDL at different time points. 
Depending on the study aims, investigators should choose the 
duration of their injury model based on these preliminary 
experiments, nevertheless other’s reports, taking in consideration 
not only biochemical, but also histopathological findings. Well-
designed study protocol is control groups are mandatory to avoid 
any ambiguous data and guarantee an accurate interpretation of 
study’s results. 
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